Redesign Health
Some leaders say AI will improve a massively inefficient, overpriced and difficult-to-access healthcare system, while others anticipate AI’s potential for earlier, more accurate diagnosis.
Some executives anticipate an acceleration of M&A activity as struggling startups seek exits, while others foresee more funding opportunities for companies with proven value in the sector.
Leaders weigh in on the digital health funding environment, women's health investments and how "AI washing" may influence capital raises.
Digital health leaders reveal the year's noteworthy events, including the rise in AI valuations, spike in demand for emergency contraception, realizations pertaining to LLMs and more.
Industry executives share their thoughts on the year's digital health developments - from an increased focus on women’s health to the rise of generative AI.
The company will fund and develop companies that focus on eight key areas in healthcare and create AI/genAI technologies that help advance those areas.
EarliTech Diagnostics secured $21.5 million, Manifold emerged with $15 million, and Beanstalk Benefits launched out of Redesign Health with $7.5 million.
Redesign Health's Pawan Kohli speaks on the current state of funding and pitfalls in digital health at HIMSS24 Venture Connect.
Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.
Digital health stakeholders said that AI will be used next year to help ease administrative tasks for providers, improve clinical trial participation and increase transparency in healthcare.